RECKITT INVESTS UP TO $600 MILLION TO ACCELERATE U.S.-BASED INNOVATION, EXPAND ACCESS TO HEALTHCARE PRODUCTS, AND STRENGTHEN SUPPLY RESILIENCE

Positive

AI Analysis

Summary

Reckitt announced up to $600 million in investment to accelerate U.S.-based innovation, expand OTC manufacturing capacity, and establish a science and innovation center in North America, with a 50% expansion of its largest OTC manufacturing facility.

Importance:3/10

Sentiment:

0.60

capital investmentmanufacturing expansionR&D investmentsupply chainOTC productsfacility expansion

Related Companies

$HR $ATALF $GBCYD

Read the original article

Published by PR Newswire Pharma on September 16, 2026 10:00 AM

Read Original